Generation and characterization of rat and mouse monoclonal antibodies specific for MeCP2 and their use in X-inactivation studies

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Jost, K Laurence ^a   Rottach, Andrea ^b   Milden, Manuela ^a   Bertulat, Bianca ^a   Becker, Annette ^a   Wolf, Patricia ^b   Sandoval, Juan ^c   Petazzi, Paolo ^c   Huertas, Dori ^c   Esteller, Manel ^c   Kremmer, Elisabeth ^d   Leonhardt, Heinrich ^b   Cardoso, M Cristina ^a  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; MONOCLONAL ANTIBODY; ANTIGEN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BRAIN TISSUE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EPITOPE MAPPING; GENE EXPRESSION; HETEROZYGOSITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MARKER GENE; MECP2 GENE; MOUSE; NONHUMAN; NULL ALLELE; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; QUANTITATIVE STUDY; SENSITIVITY ANALYSIS; SLOT BLOT HYBRIDIZATION; SPECIES DIFFERENCE; X CHROMOSOME INACTIVATION; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; BRAIN; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; CROSS REACTION; CYTOLOGY; FEMALE; GENETICS; HETEROZYGOTE; IMMUNOLOGY; MALE; METABOLISM; MOLECULAR GENETICS; RABBIT; RAT; X CHROMOSOME;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS; BRAIN; CHROMATIN IMMUNOPRECIPITATION; CROSS REACTIONS; EPITOPE MAPPING; FEMALE; HETEROZYGOTE; HUMANS; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MOLECULAR SEQUENCE DATA; RABBITS; RATS; SPECIES SPECIFICITY; X CHROMOSOME; X CHROMOSOME INACTIVATION;

EID: 82155181934     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026499     Document Type: Article

References (31)

1. Meehan RR, Lewis JD, Bird AP, (1992) Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20: 5085-5092.
2. Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, et al. (1992) Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell 69: 905-914.
3. Jones KW, (1970) Chromosomal and nuclear location of mouse satellite DNA in individual cells. Nature 225: 912-915.
4. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, et al. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19: 187-191.
5. Nan X, Campoy FJ, Bird A, (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471-481.
6. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, et al. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393: 386-389.
7. Rett A, (1966) [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien Med Wochenschr 116: 723-726.
8. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.
9. Hagberg B, (1985) Rett's syndrome: prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand 74: 405-408.
10. Hagberg B, Aicardi J, Dias K, Ramos O, (1983) A Progressive Syndrome of Autism, Dementia, Ataxia, and Loss of Purposeful Hand Use in Girls- Retts Syndrome- Report of 35 Cases. Annals Neurol 14: 471-479.
11. Amir RE, Zoghbi HY, (2000) Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations. Am J Med Genet 97: 147-152.
12. Chahrour M, Zoghbi HY, (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron 56: 422-437.
13. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY, (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11: 115-124.
14. Brero A, Easwaran HP, Nowak D, Grunewald I, Cremer T, et al. (2005) Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation. J Cell Biol 169: 733-743.
15. Agarwal N, Hardt T, Brero A, Nowak D, Rothbauer U, et al. (2007) MeCP2 interacts with HP1 and modulates its heterochromatin association during myogenic differentiation. Nucleic Acids Res 35: 5402-5408.
16. Kudo S, Nomura Y, Segawa M, Fujita N, Nakao M, et al. (2003) Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain. J Med Genet 40: 487-493.
17. Yusufzai TM, Wolffe AP, (2000) Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 28: 4172-4179.
18. Guy J, Hendrich B, Holmes M, Martin JE, Bird A, (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27: 322-326.
19. Yaffe D, Saxel O, (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270: 725-727.
20. Cardoso MC, Leonhardt H, Nadal-Ginard B, (1993) Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74: 979-992.
21. Suetake I, Mishima Y, Kimura H, Lee YH, Goto Y, et al. (2011) Characterization of DNA-binding activity in the N-terminal domain of the DNA methyltransferase Dnmt3a. Biochem J 437: 141-148.
22. Gloeckner CJ, Boldt K, Schumacher A, Roepman R, Ueffing M, (2007) A novel tandem affinity purification strategy for the efficient isolation and characterisation of native protein complexes. Proteomics 7: 4228-4234.
23. Georgel PT, Horowitz-Scherer RA, Adkins N, Woodcock CL, Wade PA, et al. (2003) Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J Biol Chem 278: 32181-32188.
24. Rottach A, Kremmer E, Nowak D, Boisguerin P, Volkmer R, et al. (2008) Generation and characterization of a rat monoclonal antibody specific for PCNA. Hybridoma 27: 91-U99.
25. Prusov AN, Zatsepina OV, (2002) Isolation of the chromocenter fraction from mouse liver nuclei. Biochemistry 67: 423-431.
26. Rottach A, Kremmer E, Nowak D, Leonhardt H, Cardoso MC, (2008) Generation and Characterization of a Rat Monoclonal Antibody Specific for Multiple Red Fluorescent Proteins. Hybridoma 27: 337-343.
27. Solovei I, Kreysing M, Lanctot C, Kosem S, Peichl L, et al. (2009) Nuclear architecture of rod photoreceptor cells adapts to vision in mammalian evolution. Cell 137: 356-368.
28. Vasiliou SA, Ali FR, Haddley K, Cardoso MC, Bubb VJ, et al. (2011) The SLC6A4 VNTR genotype determines transcription factor binding and epigenetic variation of this gene in response to cocaine in vitro. Addict Biol doi:10.1111/j.1369-1600.2010.00288.x.
29. Roux JC, Dura E, Villard L, (2008) Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse. Neurosci Lett 447: 82-86.
30. Young JI, Zoghbi HY, (2004) X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome. Am J Hum Genet 74: 511-520.
31. Gibson JH, Williamson SL, Arbuckle S, Christodoulou J, (2005) X chromosome inactivation patterns in brain in Rett syndrome: implications for the disease phenotype. Brain Dev 27: 266-270.